Literature DB >> 12528756

Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density.

H A Deutschmann1, M Weger, W Weger, P Kotanko, M J Deutschmann, F Skrabal.   

Abstract

OBJECTIVES: To determine whether the use of more elaborate diagnostic tests can identify possible risk factors for secondary osteoporosis and to evaluate the impact of these possible risk factors on the severity of bone disease in the study population.
DESIGN: Cross-sectional study. SETTING AND PARTICIPANTS: We have investigated 377 subjects (285 females, 92 males) with osteoporosis (T-score less than -2.5 in dual energy X-ray absorption) or nontraumatic lumbar vertebral fractures; these patients were referred to our hospital, a secondary care centre, for evaluation and treatment of osteoporosis.
RESULTS: Osteoporosis without attributable risk factor was diagnosed in 106 women (37%) and 30 men (33%). In 241 patients (179 women, 62 men) one or more possible risk factors for osteoporosis (in this paper also called subclinical disease) were revealed. The most common were lactose malabsorption, disturbed exocrine pancreatic function and renal tubular disturbances, including renal hypercalciuria, incomplete renal tubular acidosis and mild phosphate diabetes. The number of possible risk factors in the individual patient was significantly related to the severity of osteoporosis as assessed by Z-scores (Spearman correlation r = -0.43, P < 0.001, n = 172 for females; r = -0.28, P < 0.05, n = 65 for males).
CONCLUSIONS: All the identified subclinical diseases would have remained undetected if the currently accepted guidelines for the investigation of patients with osteoporosis were applied. The statistically significant correlation between the number of identified possible risk factors and the severity of bone disease in the individual patient strongly suggests the pathogenetic significance of the identified subclinical diseases. It is yet to be shown, whether specific treatment of these subclinical diseases yields additional improvement of bone mass as compared with standard treatment of osteoporosis.

Entities:  

Mesh:

Year:  2002        PMID: 12528756     DOI: 10.1046/j.1365-2796.2002.01040.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  18 in total

1.  The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis.

Authors:  F E McKiernan; R L Berg; J G Linneman
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

2.  Short-term and long-term orthopaedic issues in patients with fragility fractures.

Authors:  Susan V Bukata; Stephen L Kates; Regis J O'Keefe
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

3.  Bone: Is screening for secondary causes of osteoporosis worthwhile?

Authors:  J Chris Gallagher; Adarsh J Sai
Journal:  Nat Rev Endocrinol       Date:  2010-07       Impact factor: 43.330

4.  A guide to improving the care of patients with fragility fractures.

Authors:  Susan V Bukata; Benedict F Digiovanni; Susan M Friedman; Harry Hoyen; Amy Kates; Stephen L Kates; Simon C Mears; Daniel A Mendelson; Fernando H Serna; Frederick E Sieber; Wakenda K Tyler
Journal:  Geriatr Orthop Surg Rehabil       Date:  2011-01

Review 5.  Osteoporosis, frailty and fracture: implications for case finding and therapy.

Authors:  Joop P van den Bergh; Tineke A van Geel; Piet P Geusens
Journal:  Nat Rev Rheumatol       Date:  2012-01-17       Impact factor: 20.543

6.  Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.

Authors:  J L Casado; S Bañon; R Andrés; M J Perez-Elías; A Moreno; S Moreno
Journal:  Osteoporos Int       Date:  2013-09-21       Impact factor: 4.507

7.  Prevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis.

Authors:  Spyridon Arampatzis; Barbara Röpke-Rieben; Kurt Lippuner; Bernhard Hess
Journal:  Urol Res       Date:  2011-06-29

8.  Osteoporosis in men: insights for the clinician.

Authors:  Robert A Adler
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-08       Impact factor: 5.346

9.  Bone disease in primary hypercalciuria.

Authors:  Stefania Sella; Catia Cattelan; Giuseppe Realdi; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

10.  Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis.

Authors:  Clarita V Odvina; John R Poindexter; Roy D Peterson; Joseph E Zerwekh; Charles Y C Pak
Journal:  Urol Res       Date:  2008-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.